Arkolith/Insider Trading/UBX/Form 4

Ghosh Anirvan

Chief Executive Officer, DirectorUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed Mar 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2025Grant(A)175K—$0250K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2025Grant(A)286K—$0286K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-047731) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML